MBX Biosciences, Inc. Share Price
NASDAQ: MBX | Mid CapMBX Biosciences, Inc. Stock Performance
Open $69.19 | Prev. Close $66.98 | Circuit Range N/A |
Day Range $65.41 - $69.32 | Year Range $9.64 - $71.83 | Volume 76,926 |
Average Traded $67.03 |
MBX Biosciences, Inc. Share Price Today
As of 10 August 2026, MBX Biosciences, Inc.'s share price is $67.82. The stock opened at $69.19, compared to its previous close of $66.98. During today's trading session, MBX Biosciences, Inc.'s share price traded between $65.41 and $69.32, with an average price of $67.36. Over the past 52 weeks, the stock has recorded a high of $71.83 and a low of $9.64. In terms of performance, MBX Biosciences, Inc.'s share price has risen by 108.81% over the last six months and is up 347.51% on a year-on-year basis.
MBX Biosciences, Inc. Share Price Chart
MBX Biosciences, Inc. Stock Fundamentals & Key Indicators
Market Cap $2.48B | PE Ratio (TTM) -28.50 | Dividend Yield N/A |
EPS (TTM) $-2.38 | Revenue (TTM) N/A | Return On Equity (TTM) -23.56% |
Profit Margin N/A | Debt to Equity 0.04 | Quarterly Earnings Growth YoY -19.16% |
MBX Biosciences, Inc. Quarterly Profit & Loss
All figures in USD
MBX Biosciences, Inc. Annual Profit & Loss
All figures in USD
About MBX Biosciences, Inc.
MBX Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of precision peptide therapies for the treatment of endocrine and metabolic disorders. Its lead product candidate is MBX 2109, a parathyroid hormone peptide prodrug, which is in Phase 2 clinical trial for the treatment of chronic hypoparathyroidism. The company is also developing MBX 1416, a long-acting glucagon-like peptide-1 (GLP-1) receptor antagonist that is in Phase 1 clinical trial a potential therapy for post-bariatric hypoglycemia, a chronic complication of bariatric surgery. In addition, it is developing MBX 4291, a lead obesity product candidate, which is in investigational new drug-enabling studies for the treatment of obesity and co-morbidities. The company was founded in 2018 and is based in Carmel, Indiana.
MBX Biosciences, Inc. Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Aug 2026 | $65.69 | $67.75 | +2.71% |
Jul 2026 | $55.40 | $65.96 | +19.54% |
Jun 2026 | $31.57 | $55.18 | +75.06% |
May 2026 | $30.48 | $31.52 | +4.25% |
Apr 2026 | $31.21 | $30.23 | +1.21% |
Mar 2026 | $31.99 | $29.88 | -8.02% |
Feb 2026 | $38.31 | $32.48 | -11.86% |
Jan 2026 | $31.28 | $36.85 | +16.71% |
Dec 2025 | $34.04 | $31.57 | -8.43% |
Nov 2025 | $22.01 | $34.48 | +56.80% |
Oct 2025 | $17.95 | $21.99 | +25.62% |
Sep 2025 | $15.13 | $17.50 | +15.51% |
MBX Share Price FAQs
What is MBX Biosciences, Inc. share price today?
What is the 52 week high and 52 week low of MBX Biosciences, Inc. stock?
What is MBX's market capitalisation today?
What is MBX's net income for the last quarter?
What is the 5 year returns of MBX?
What is the high & low stock price of MBX today?
Can I buy MBX shares in India?